The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
Bangladesh · Delayed Price · Currency is BDT 313.90
+0.10 (0.03%)
At close: Jun 16, 2026
DSE:IBNSINA Market Cap
DSE:IBNSINA has a market cap or net worth of 9.81 billion as of June 16, 2026. Its market cap has increased by 6.81% in one year.
Market Cap
9.81B
Enterprise Value
13.10B
Revenue
13.48B
Ranking
n/a
PE Ratio
12.44
Stock Price
313.90
Market Cap Chart
Since May 3, 2012, DSE:IBNSINA's market cap has increased from 1.73B to 9.81B, an increase of 466.85%. That is a compound annual growth rate of 13.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 9.81B | -0.03% |
| Dec 30, 2025 | 9.81B | 9.48% |
| Dec 30, 2024 | 8.96B | 0.07% |
| Dec 28, 2023 | 8.95B | - |
| Dec 29, 2022 | 8.95B | 5.64% |
| Dec 30, 2021 | 8.48B | 11.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Renata | 50.34B |
| Unilever Consumer Care | 39.79B |
| Beacon Pharmaceuticals | 26.03B |
| The ACME Laboratories | 17.06B |
| Asiatic Laboratories | 15.19B |
| Navana Pharmaceuticals | 7.76B |
| Orion Pharma | 6.76B |
| Techno Drugs | 5.85B |